Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter?
Background: Mycoplasma pneumoniae is a common pathogen for pneumonia in children, especially in the post-pneumococcal conjugate vaccination era. Though self-limited disease was found in the majority of the patients, severe diseases occurred occasionally. The emergence of macrolide resistance was rep...
Main Authors: | Tzu-I Yang, Tu-Hsuan Chang, Chun-Yi Lu, Jong-Min Chen, Ping-Ing Lee, Li-Min Huang, Luan-Yin Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118218301865 |
Similar Items
-
Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
by: Yu-Chin Chen, et al.
Published: (2020-07-01) -
Severe Mycoplasma pneumoniae infections with prolonged fever in a child: Delayed treatment is as important as macrolide resistance
by: Jun Yi Sim, et al.
Published: (2021-04-01) -
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
by: Nobuhisa Ishiguro, et al.
Published: (2017-01-01) -
Macrolide-Resistant Mycoplasma pneumoniae, United States
by: Xiaotian Zheng, et al.
Published: (2015-08-01) -
Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
by: Diana Averbuch, et al.
Published: (2011-06-01)